Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

Phase 3 Completed 150 enrolled Sumitomo Pharma America, Inc.

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a study to investigate the reliability, ruggedness and safety of the top mounted actuation indicator (TMAI) when used with Levalbuterol HFA MDI.

Timeline

Start: 2005-09
Primary completion: 2006-01
Completion: 2006-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Levalbuterol	Other / unclassified	—	Inhaled

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

Summary

Timeline

Drugs

Indications